Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05071027 · ClinicalTrials.gov registry record · NA
Dual Antiplatelet Therapy Adherence With Reminder App Usage
A NA study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05071027 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT05071027, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate Dual Antiplatelet Therapy adherence in patients undergoing stent-based endovascular treatment for unruptured cervical and intradural, intracranial aneurysms. Patients will be randomized on a 1:1 basis to either a medication reminder app group or a control group, with patients in both groups receiving the standard of care. The app in question, Endovascular Neurosurgery, is available on the app store. The app does not collect user data and has not been officially deemed HIPAA compliant. The only data inputted into the app are the patient's procedure date and the antiplatelet medications the patient has been prescribed. The app does not possess sensitive patient data. Patients will input the time notifications will be sent and the app will be available in both Spanish and English. The investigators will be assessing medication adherence via the Adherence Barriers Questionnaire.
Interventions
- OTHER Endovascular Neurosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2024-07-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05071027
The ClinicalTrials.gov registry entry for NCT05071027 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endovascular Neurosurgery is the first listed.
NCT05071027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05071027 about?
NCT05071027 is a clinical study titled "Dual Antiplatelet Therapy Adherence With Reminder App Usage". The purpose of this study is to evaluate Dual Antiplatelet Therapy adherence in patients undergoing stent-based endovascular treatment for unruptured cervical and intradural, intracranial aneurysms. Patients will be randomized on a 1:1 basis to either a medication reminder app group or a control gro...
What is the current status of trial NCT05071027?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2021-10-27. Estimated completion is 2024-07-22.
What interventions are being tested in trial NCT05071027?
The interventions under investigation include: Endovascular Neurosurgery (OTHER).
Who is sponsoring clinical trial NCT05071027?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.